Qian Hui, Lu Zhong, Ding Huilin, Yan Shuxian, Xiang Leihong, Gold Michael H
Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China.
J Cosmet Laser Ther. 2012 Aug;14(4):162-5. doi: 10.3109/14764172.2012.699679.
Fractional ablative CO(2) laser therapy is based on the theory of fractional photothermolysis. It can be effective in treating acne scars in a less invasive fashion than conventional ablative CO(2) laser therapy.
In this clinical study, the safety and efficacy of a novel CO(2) fractional ablative laser was investigated for the treatment of facial atrophic acne scarring in Chinese individuals.
A total of 31 patients (11 females, 20 males, Fitzpatrick skin phototypes III-IV) with facial acne scarring received three sequential fractional treatments over a 6-month period. Outcome measurements included blinded evaluations of before and after photographs by two physicians at 3 and 12 months after the final treatment. Global improvement was noted as well as any untoward events.
At the 12 months follow-up time period, 12.9% of the patients showed excellent improvement in their acne scars, while 38.71% noted good to fair results. The clinical response at the 12-month follow-up visit tended to be better than at the 3-month follow-up visit, but was not statistically significant. Four patients experienced post-treatment and transient PIH but three patients were noted to have prolonged erythema. There was no evidence hypopigmentation or worsening of the scarring in any of the study patients.
This high-energy pulsed and cool-scanned fractional ablative CO(2) laser system is safe and effective for facial atrophic acne scarring. Improvement in scarring was noted in the majority of patients with minimal discomfort and minimal downtime. Continued improvement over time is also an important clinical finding.
非剥脱性二氧化碳激光治疗基于选择性光热解理论。与传统剥脱性二氧化碳激光治疗相比,它能以侵入性较小的方式有效治疗痤疮瘢痕。
在这项临床研究中,研究了一种新型二氧化碳非剥脱性激光治疗中国人群面部萎缩性痤疮瘢痕的安全性和有效性。
共有31例面部有痤疮瘢痕的患者(11例女性,20例男性,Fitzpatrick皮肤光类型III - IV)在6个月内接受了三次连续的非剥脱性治疗。结果测量包括在最后一次治疗后3个月和12个月由两名医生对治疗前后照片进行盲法评估。记录整体改善情况以及任何不良事件。
在12个月的随访期内,12.9%的患者痤疮瘢痕有显著改善,而38.71%的患者效果良好至中等。12个月随访时的临床反应往往比3个月随访时更好,但无统计学意义。4例患者出现治疗后短暂性炎症后色素沉着,但3例患者出现持续性红斑。在任何研究患者中均未发现色素减退或瘢痕恶化的证据。
这种高能脉冲和冷扫描非剥脱性二氧化碳激光系统对面部萎缩性痤疮瘢痕安全有效。大多数患者瘢痕得到改善,不适轻微,停工期短。随着时间的推移持续改善也是一项重要的临床发现。